Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Amgen, Inc. (NQ: AMGN)
101.50 USD  +2.42 (+2.44%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Amgen, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
86 87 Next >
Amgen (AMGN) Boosts Cytokinetics (CYTK) to 7.58%
Today 17:31 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8428826 for the full story. Read More
from StreetInsider.com News Articles
Interesting Similarities Among 2013's Top-Performing ETFs
Today 16:09 EDT
With 2013 nearly half complete, now is a good time to look at this year's top-performing ETFs to see what has worked, what might keep working and which funds could be vulnerable to second-half... Read More
category Specialty ETFs , Benzinga , PBE , and 24 more.
from Latest Articles from Benzinga.com
Cytokinetics (CYTK) ATOMIC-AHF Results to Be Presented at ESC Congress 2013 (AMGN)
Today 8:32 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8426044 for the full story. Read More
from StreetInsider.com News Articles
Barron's Recap: Midyear Roundtable
June 17, 2013
This past weekend in Barron's online: the midyear 2013 roundtable, and the prospects for Eastman Chemical, BB&T, Amgen and Big Lots. Cover Story " Shifting Winds " by Lauren R. Rublin. The investment... Read More
category amgen , BIG , Benzinga , and 14 more.
from Latest Articles from Benzinga.com
Amgen share buybacks, drugs may fuel more stock gains - Barron's
June 16, 2013
June 16 (Reuters) - Amgen Inc, the world's largest biotechnology company, has plenty of room to grow despite a 43 percent jump in its share price over the past year, thanks to cost cuts, newer drugs... Read More
category companyNews
from Reuters: Company News
New Amgen Drug Receives FDA Approval (AMGN)
June 13, 2013
Biopharmaceutical firm Amgen (AMGN) has just had a major new drug, called “XGEVA,” approved by the FDA. XGEVA will be used to treat patients with giant cell tumor of bone (GCTB) where surgery presents... Read More
category amgen , amgn , Dividend Stocks
from Dividend Daily
FDA Approves Amgen's (AMGN) XGEVA for GCTB
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8415284 for the full story. Read More
from StreetInsider.com News Articles
FDA Issues Approval for Xgeva, Marketed by Amgen
June 13, 2013
The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually... Read More
category Benzinga , AMGN , News , and 1 more.
from Latest Articles from Benzinga.com
Needham & Company Sees 150% Upside in Cytokinetics (CYTK) after Expanded Amgen (AMGN) Deal
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8413213 for the full story. Read More
from StreetInsider.com News Articles
Income hunters: Bank on this dividend stock play
June 13, 2013
Paying a dividend vs. buying back shares is a debate investors should feel fortunate about. Companies with such a choice are fundamentally sound, and those that can do both simultaneously are even... Read More
category Earnings , VZ , T , and 59 more.
from MarketWatch
Amgen’s AMG-386 Still Not Meeting FDA Standards (AMGN)
June 12, 2013
California bio-pharmaceutical company Amgen (AMGN) will likely need to make more improvements to its ovarian cancer drug, AMG-386, in order to gain FDA approval. RBC analyst Michael Yee stated earlier... Read More
category amgn , Dividend Stocks
from Dividend Daily
RBC Says Amgen's AMG-386 Will Need to See Increases in Overall Survival Benefits Before FDA Approval
June 12, 2013
Amgen's (NASDAQ: AMGN ) ovarian cancer drug AMG-386 will need to show palpable increases in overall survival benefits in order to gain FDA approval, according to RBC analyst Michael Yee in a research... Read More
category Benzinga , AMGN , News , and 3 more.
from Latest Articles from Benzinga.com
Markets Turn Negative At Midday
June 12, 2013
The volatile markets turned negative during the midday with the Dow dropping 69 points to 15,052 over renewed concerns about the global economy. Nasdaq tumbled 24 points to 3412. Read More
category Market News
from MarketMinute.com Market Updates
Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)
June 12, 2013
Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB ), saw the most significant rise in short interest between the May 15 and May 31 settlement dates. The number of shares... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Deutsche Bank Maintains “Buy” Rating on Amgen (AMGN)
June 12, 2013
Deutsche Bank reported on Wednesday that it has reiterated a “Buy” rating on biotechnology company, Amgen, Inc. (AMGN). The firm has maintained a “Buy” rating on AMGN, and has given the company a $115... Read More
category amgen , amgn , Dividend Stocks
from Dividend Daily
Deutsche Bank Maintains Buy on Amgen (AMGN)
June 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8409574 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 1-Amgen says drug slowed ovarian cancer in trial
June 12, 2013
June 12 (Reuters) - Amgen Inc's trebananib drug for ovarian cancer extended the length of time that patients lived without the disease getting worse by about two months, meeting the main goal of a... Read More
category companyNews
from Reuters: Company News
Notable ETF Outflow Detected - IBB, REGN, AMGN, CELG
June 12, 2013
Symbols mentioned in this story: IBB, REGN, AMGN, CELG Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
category ETFs
from ETF Channel
Amgen says trebananib reduces risk of ovarian cancer in trial
June 12, 2013
June 12 (Reuters) - Amgen Inc said on Wednesday that its trebananib treatment for ovarian cancer had reduced the risk of disease progression or death by 34 percent in a clinical trial. Read More
category companyNews
from Reuters: Company News
StreetInsider.com Pre-Open Movers 6/12: (CTB) (CYTK) (HMA) Higher; (CLSN) (FSLR) (IEP) Lower (more...)
June 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8409003 for the full story. Read More
from StreetInsider.com News Articles
Amgen (AMGN) Phase 3 TRINOVA-1 Met Primary Endpoint
June 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8408882 for the full story. Read More
from StreetInsider.com News Articles
Amgen (AMGN), AstraZeneca (AZN) to Present Brodalumab Data; Will Advance Into Phase 3
June 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8408658 for the full story. Read More
from StreetInsider.com News Articles
Amgen (AMGN), Cytokinetics (CYTK) Expand Collaboration Into Japan
June 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8408326 for the full story. Read More
from StreetInsider.com News Articles
StockCall Early Morning Insight into AFFY, AMGN, PDLI, QCOR, and BCRX
June 07, 2013
from ACCESSWIRE
Lightning Round: Amgen, Ford & More
June 05, 2013
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites. Read More
category 8x8 Inc , Lightning Round , Mad Money for Mobile , and 8 more.
from CNBC.com News
Altria Group Inc Moves Up In Market Cap Rank, Passing Amgen Inc
June 05, 2013
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Altria Group Inc (MO) has taken over the #44 spot from Amgen Inc (AMGN), according to The Online... Read More
category Stocks
from Market News Video
Too Much Selling of Top Ranked Dividend Stock AMGN
June 05, 2013
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important... Read More
category Dividends
from Dividend Channel
Genomics and particle physics top the scientific charts
June 05, 2013
* Genomics hottest field of study in 2012 - Thomson Reuters Read More
category companyNews
from Reuters: Company News
Agree To Purchase Amgen Inc At $75, Earn 7.7%
June 04, 2013
Investors considering a purchase of Amgen Inc (AMGN) stock, but tentative about paying the going market price of $98.54/share, might benefit from considering selling puts among the alternative... Read More
category Stocks
from Market News Video
Agree To Purchase Amgen Inc At $75, Earn 7.7%
June 04, 2013
Investors considering a purchase of Amgen Inc (AMGN) stock, but tentative about paying the going market price of $98.54/share, might benefit from considering selling puts among the alternative... Read More
category Dividends
from Dividend Channel
< Previous 1 2 3 4 5 6 7 8 9
...
86 87 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here